The development of proteasome inhibitors as anticancer drugs
Infinity Pharmaceuticals (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
779
total citations
- FWCI
- 24.64
- Percentile
- 100%
- References
- 61
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Bortezomib
- Proteasome
- Multiple myeloma
- Proteasome inhibitor
- Cancer research
- Clinical trial
- Cytotoxic T cell
- Pharmacology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.